Skip to main content
. 2020 Feb 24;8(1):101. doi: 10.3390/vaccines8010101

Figure 1.

Figure 1

Steps involved in developing a causality assessment guideline for Guillain–Barré syndrome following immunization. (AEFI: Adverse Events Following Immunization; BC: Brighton Collaboration; EIS: Epidemiology Intelligence Service; GBS: Guillain–Barré syndrome; VICEC: Vaccine Injury Compensation Expert Committee; VIIU: Vaccine Injury Investigation Unit).